AstraZeneca Stock Up On Report FDA Could Soon OK Its Coronavirus VaccineInvestors Business Daily • 08/24/20
AstraZeneca's Coronavirus Vaccine Could Get FDA Approval For Emergency Use By October: FTBenzinga • 08/24/20
Trump wants to fast-track Oxford's potential coronavirus vaccine in time for election - reportSkynews • 08/23/20
Coronavirus Vaccine Companies Target Best-Case Timeline — But What's The Worst Case?Investors Business Daily • 08/21/20
These 4 Drugmakers Are Using AI to Improve Their Products. Does It Make Them Better Buys?The Motley Fool • 08/15/20
EU reaches deal with AstraZeneca for at least 300 million doses of potential Covid-19 vaccineCNBC • 08/14/20
The U.S. has already invested billions on potential coronavirus vaccines. Here's where the deals standCNBC • 08/14/20
European Commission agrees to buy 300 million doses of AstraZeneca COVID-19 vaccineMarket Watch • 08/14/20
AstraZeneca Ships FLUMIST® QUADRIVALENT Vaccine in the US for 2020-2021 Flu SeasonBusiness Wire • 08/13/20
AstraZeneca Inks Deal With Mexico, Argentina For Production, Supply Of Its COVID-19 Vaccine To Latin AmericaBenzinga • 08/13/20
AstraZeneca Partners with Actor and Author Tony Hale to Build Awareness of Eosinophilic Asthma and How Not All Asthma is the SameBusiness Wire • 08/11/20
T Cell Responses To Coronavirus Vaccines Are In The Interest Of National SecuritySeeking Alpha • 08/10/20
LogicBio Therapeutics Announces SUNRISE Phase 1/2 Clinical Design for LB-001 for the Treatment of Methylmalonic Acidemia in Pediatric PatientsGlobeNewsWire • 08/10/20
LogicBio Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business UpdatesGlobeNewsWire • 08/10/20